Management of haemophilic patients with inhibitors in major orthopaedic surgery by immunadsorption, substitution of factor VIII and recombinant factor VIIa (NovoSeven®): a single centre experience - Habermann, B.; Hochmuth, K.; Hovy, L.; Scharrer, I.; Kurth, A. H. A. (Blackwell Science Ltd, 2004)
http://dx.doi.org/10.1111/j.1365-2516.2004.01037.x
Keywords: WW-YZ